Merck Merck
Stories About

Merck

President Biden keeps a note card in his suit pocket with the running tally of how many Americans have died from COVID-19 and how many have been vaccinated. Evan Vucci/AP hide caption

toggle caption
Evan Vucci/AP

How The White House Got 2 Pharma Rivals To Work Together On COVID-19 Vaccine

  • Download
  • <iframe src="https://www.npr.org/player/embed/973117712/973198250" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Pharmaceutical giant Merck will help manufacture Johnson & Johnson's COVID-19 vaccine. Alex Gottschalk/DeFodi Images via Getty Images hide caption

toggle caption
Alex Gottschalk/DeFodi Images via Getty Images

Pharmaceutical company Merck says it is shelving its two COVID-19 vaccine candidates, saying that the results of clinical trials fell short of its goals. Budrul Chukrut/SOPA Images/LightRocket via Getty Images hide caption

toggle caption
Budrul Chukrut/SOPA Images/LightRocket via Getty Images

A nurse vaccinates a baby against rotavirus, a deadly form of diarrhea. Hector Retamal/AFP/Getty Images hide caption

toggle caption
Hector Retamal/AFP/Getty Images

Merck Pulls Out Of Agreement To Supply Life-Saving Vaccine To Millions Of Kids

  • Download
  • <iframe src="https://www.npr.org/player/embed/655844287/662877476" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Kenneth Frazier, the CEO of Merck, said he was stepping down from a business council as a matter of personal conscience. He's seen here with President Trump during a White House event in July. Saul Loeb/AFP/Getty Images hide caption

toggle caption
Saul Loeb/AFP/Getty Images

Cattle in holding pens at the Simplot feedlot located next to a slaughterhouse in Burbank, Washington on Dec. 26, 2013. Merck & Co Inc is testing lower dosages of its controversial cattle growth drug Zilmax drug in an effort to resume its sales to the $44 billion U.S. beef industry. Ross Courtney/Reuters/Landov hide caption

toggle caption
Ross Courtney/Reuters/Landov